150 related articles for article (PubMed ID: 12745652)
1. c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
Aref S; Fouda M; El-Dosoky E; Menessy A; Mabed M; Saleeb M; Zalata K
Hematology; 2003 Jun; 8(3):183-90. PubMed ID: 12745652
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
3. cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas.
Hernández S; Hernández L; Beà S; Cazorla M; Fernández PL; Nadal A; Muntané J; Mallofré C; Montserrat E; Cardesa A; Campo E
Cancer Res; 1998 Apr; 58(8):1762-7. PubMed ID: 9563496
[TBL] [Abstract][Full Text] [Related]
4. cdc25a and the splicing variant cdc25b2, but not cdc25B1, -B3 or -C, are over-expressed in aggressive human non-Hodgkin's lymphomas.
Hernández S; Hernández L; Bea S; Pinyol M; Nayach I; Bellosillo B; Nadal A; Ferrer A; Fernández PL; Montserrat E; Cardesa A; Campo E
Int J Cancer; 2000 Mar; 89(2):148-52. PubMed ID: 10754492
[TBL] [Abstract][Full Text] [Related]
5. c-myc mRNA expression in non-Hodgkin's lymphomas.
Fellbaum C; Radaszkiewicz T; Ruhri C; Pütz B; Lehmacher W; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):61-8. PubMed ID: 1352077
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
Ikeguchi M; Hirooka Y
Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
[TBL] [Abstract][Full Text] [Related]
7. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
Korkolopoulou P; Oates J; Kittas C; Crocker J
J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.
Wu W; Fan YH; Kemp BL; Walsh G; Mao L
Cancer Res; 1998 Sep; 58(18):4082-5. PubMed ID: 9751615
[TBL] [Abstract][Full Text] [Related]
9. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.
Lossos IS; Czerwinski DK; Wechser MA; Levy R
Leukemia; 2003 Apr; 17(4):789-95. PubMed ID: 12682639
[TBL] [Abstract][Full Text] [Related]
10. The interplay between c-Myc oncogene expression and circulating vascular endothelial growth factor (sVEGF), its antagonist receptor, soluble Flt-1 in diffuse large B cell lymphoma (DLBCL): relationship to patient outcome.
Aref S; Mabed M; Zalata K; Sakrana M; El Askalany H
Leuk Lymphoma; 2004 Mar; 45(3):499-506. PubMed ID: 15160911
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of EBV, Bcl-2, p53, c-Myc and Rb in non-Hodgkin's lymphoma.
Song W; Liu MG; Zhang JB; Zhang JJ; Sun MM; Yu QK
Eur Rev Med Pharmacol Sci; 2016; 20(6):1093-7. PubMed ID: 27049262
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
[TBL] [Abstract][Full Text] [Related]
13. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of Livin expression in non-Hodgkin's lymphoma].
Gao JM; Wang X; Liu XQ; Ge XL; Ding M; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):385-90. PubMed ID: 20416174
[TBL] [Abstract][Full Text] [Related]
15. Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities.
Møller MB; Nielsen O; Pedersen NT
Mod Pathol; 1999 Nov; 12(11):1010-6. PubMed ID: 10574597
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
Nishioka K; Doki Y; Shiozaki H; Yamamoto H; Tamura S; Yasuda T; Fujiwara Y; Yano M; Miyata H; Kishi K; Nakagawa H; Shamma A; Monden M
Br J Cancer; 2001 Aug; 85(3):412-21. PubMed ID: 11487274
[TBL] [Abstract][Full Text] [Related]
17. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
[TBL] [Abstract][Full Text] [Related]
18. N-myc protein expression in human breast carcinoma: prognostic implications.
Mizukami Y; Nonomura A; Takizawa T; Noguchi M; Michigishi T; Nakamura S; Ishizaki T
Anticancer Res; 1995; 15(6B):2899-905. PubMed ID: 8669886
[TBL] [Abstract][Full Text] [Related]
19. Cdc25A phosphatase suppresses apoptosis induced by serum deprivation.
Fuhrmann G; Leisser C; Rosenberger G; Grusch M; Huettenbrenner S; Halama T; Mosberger I; Sasgary S; Cerni C; Krupitza G
Oncogene; 2001 Jul; 20(33):4542-53. PubMed ID: 11494150
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of Ki-67 antigen and c-myc oncoprotein in malignant fibrous histocytoma.
Brinck U; Stachura J; Kellner S; Schauer A
Anticancer Res; 1995; 15(5B):1915-9. PubMed ID: 8572578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
